Chris R. Alabiad, MD: There wasn’t one single national rule change in 2025 that transformed residency training overnight.
Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...
Veterinary ophthalmologists bridge the gap between clinical surgery and comparative research, ensuring regulatory compliance ...
Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...
YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
OMAHA, NE - January 08, 2026 - PRESSADVANTAGE - Kugler Vision announced the publication of its new feature, “Dr. Lance ...
“Dr. Choudhary has been instrumental in driving quality and clinical excellence at Tradition Hospital,” said Dr. Conor ...
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets –– Pivotal Phase 3 trials in ...
Quickparts invests $2.5M in Seattle expansion and launches Quick Mold rapid tooling solution for faster product development ...
CAI Performance Additives, a developer of advanced polymer additive technologies, has unveiled ST-MCA-H, a high-efficiency, ...
Studio arts, performing arts and engineering programs at Amherst Regional High School are being supported with a $30,000 gift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback